18-36640528-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001281740.3(FHOD3):​c.1197-8788T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.393 in 152,102 control chromosomes in the GnomAD database, including 12,693 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12693 hom., cov: 32)

Consequence

FHOD3
NM_001281740.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.07

Publications

8 publications found
Variant links:
Genes affected
FHOD3 (HGNC:26178): (formin homology 2 domain containing 3) The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
FHOD3 Gene-Disease associations (from GenCC):
  • cardiomyopathy, familial hypertrophic, 28
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.539 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001281740.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHOD3
NM_001281740.3
MANE Select
c.1197-8788T>C
intron
N/ANP_001268669.1
FHOD3
NM_025135.5
c.1196+14779T>C
intron
N/ANP_079411.2
FHOD3
NM_001281739.3
c.1196+14779T>C
intron
N/ANP_001268668.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHOD3
ENST00000590592.6
TSL:1 MANE Select
c.1197-8788T>C
intron
N/AENSP00000466937.1
FHOD3
ENST00000257209.8
TSL:1
c.1196+14779T>C
intron
N/AENSP00000257209.3
FHOD3
ENST00000359247.8
TSL:1
c.1196+14779T>C
intron
N/AENSP00000352186.3

Frequencies

GnomAD3 genomes
AF:
0.393
AC:
59655
AN:
151984
Hom.:
12674
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.545
Gnomad AMI
AF:
0.350
Gnomad AMR
AF:
0.441
Gnomad ASJ
AF:
0.350
Gnomad EAS
AF:
0.433
Gnomad SAS
AF:
0.480
Gnomad FIN
AF:
0.178
Gnomad MID
AF:
0.364
Gnomad NFE
AF:
0.316
Gnomad OTH
AF:
0.386
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.393
AC:
59719
AN:
152102
Hom.:
12693
Cov.:
32
AF XY:
0.390
AC XY:
28996
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.545
AC:
22608
AN:
41476
American (AMR)
AF:
0.442
AC:
6751
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.350
AC:
1213
AN:
3466
East Asian (EAS)
AF:
0.434
AC:
2247
AN:
5178
South Asian (SAS)
AF:
0.479
AC:
2308
AN:
4820
European-Finnish (FIN)
AF:
0.178
AC:
1891
AN:
10596
Middle Eastern (MID)
AF:
0.350
AC:
103
AN:
294
European-Non Finnish (NFE)
AF:
0.316
AC:
21462
AN:
67970
Other (OTH)
AF:
0.387
AC:
817
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1816
3631
5447
7262
9078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.351
Hom.:
5535
Bravo
AF:
0.414
Asia WGS
AF:
0.468
AC:
1625
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.2
DANN
Benign
0.61
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2644261; hg19: chr18-34220491; API